News|Articles|January 1, 2003
- Pharmaceutical Technology-01-01-2003
- Volume 27
- Issue 1
Outsourcing Outlook
Author(s)Jim Miller
Developments in 2002 such as acquisitions, excess manufacturing capacity, and less funding for biotechnology will continue to affect the industry long into the new year.
Advertisement
Articles in this issue
about 23 years ago
Pharmaceutical Pricing and Innovation Key Issues for 2003about 23 years ago
Procedures: Improving Their Qualityabout 23 years ago
Drug-Carrier Screening on a Chipabout 23 years ago
Pack EXPO International 2002 Proves Worth the Tripabout 23 years ago
Analysis of the Indian Pharmaceutical IndustryNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Amgen Acquires UK Biotech Dark Blue Therapeutics
2
Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP
3
From AI to Smart Factories: How Pharma Is Preparing for 2026
4
FUJIFILM Irvine Scientific Becomes FUJIFILM Biosciences
5